{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:55:19Z","timestamp":1793692519195,"version":"4.5.1"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005088","name":"Beijing Municipal Health Commission","doi-asserted-by":"publisher","award":["2205-110000-04-03-959056"],"award-info":[{"award-number":["2205-110000-04-03-959056"]}],"id":[{"id":"10.13039\/501100005088","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005088","name":"Beijing Municipal Health Commission","doi-asserted-by":"publisher","award":["BRWEP2024W032040203"],"award-info":[{"award-number":["BRWEP2024W032040203"]}],"id":[{"id":"10.13039\/501100005088","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82192894"],"award-info":[{"award-number":["82192894"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272870"],"award-info":[{"award-number":["82272870"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202896"],"award-info":[{"award-number":["82202896"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.redox.2025.103827","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T15:11:53Z","timestamp":1756480313000},"page":"103827","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Novel Thioredoxin reductase 1 inhibitor BS1801 relieves treatment resistance and triggers endoplasmic reticulum stress by elevating reactive oxygen species in glioma"],"prefix":"10.1016","volume":"86","author":[{"given":"Yuanhao","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanwei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanzhang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5351-2155","authenticated-orcid":false,"given":"Fan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.redox.2025.103827_bib1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.canlet.2020.10.050","article-title":"Clinical practice guidelines for the management of adult diffuse gliomas","volume":"499","author":"Jiang","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.redox.2025.103827_bib2","article-title":"Glioblastoma: clinical presentation, diagnosis, and management","volume":"374","author":"McKinnon","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.redox.2025.103827_bib3","first-page":"166","article-title":"Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma","volume":"60","author":"Van Meir","year":"2010","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.redox.2025.103827_bib4","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/neuonc\/noaa106","article-title":"Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions","volume":"22","author":"Wen","year":"2020","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.redox.2025.103827_bib5","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1001\/jama.2023.0023","article-title":"Glioblastoma and other primary brain malignancies in adults: a review","volume":"329","author":"Schaff","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.redox.2025.103827_bib6","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.redox.2025.103827_bib7","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1158\/1078-0432.CCR-21-2750","article-title":"Glioblastoma clinical trials: current landscape and opportunities for improvement","volume":"28","author":"Bagley","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.redox.2025.103827_bib8","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.cell.2018.09.038","article-title":"Mutational landscape of secondary glioblastoma guides MET-targeted trial in brain tumor","volume":"175","author":"Hu","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.redox.2025.103827_bib9","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1200\/JCO.21.02036","article-title":"Therapy for diffuse astrocytic and oligodendroglial tumors in adults: ASCO-SNO guideline","volume":"40","author":"Mohile","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.redox.2025.103827_bib10","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1470-2045(21)00090-5","article-title":"Adjuvant and concurrent temozolomide for 1p\/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study","volume":"22","author":"van den Bent","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.redox.2025.103827_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188616","article-title":"Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance","volume":"1876","author":"Tomar","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.redox.2025.103827_bib12","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/neuonc\/noab003","article-title":"PARP-mediated PARylation of MGMT is critical to promote repair of temozolomide-induced O6-methylguanine DNA damage in glioblastoma","volume":"23","author":"Wu","year":"2021","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.redox.2025.103827_bib13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1215\/15228517-2008-090","article-title":"Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts","volume":"11","author":"Kitange","year":"2009","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.redox.2025.103827_bib14","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.gendis.2016.04.007","article-title":"Temozolomide resistance in glioblastoma multiforme","volume":"3","author":"Lee","year":"2016","journal-title":"Genes Dis."},{"key":"10.1016\/j.redox.2025.103827_bib15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/neuonc\/noy132","article-title":"MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges","volume":"21","author":"Mansouri","year":"2019","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.redox.2025.103827_bib16","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.7150\/thno.41219","article-title":"ATRX\/EZH2 complex epigenetically regulates FADD\/PARP1 axis, contributing to TMZ resistance in glioma","volume":"10","author":"Han","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.redox.2025.103827_bib17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13073-023-01165-8","article-title":"Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma","volume":"15","author":"Nam","year":"2023","journal-title":"Genome Med."},{"key":"10.1016\/j.redox.2025.103827_bib18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12929-022-00804-3","article-title":"Reprogramming of arachidonate metabolism confers temozolomide resistance to glioblastoma through enhancing mitochondrial activity in fatty acid oxidation","volume":"29","author":"Tsai","year":"2022","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.redox.2025.103827_bib19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41568-019-0226-5","article-title":"Altered cellular metabolism in gliomas - an emerging landscape of actionable co-dependency targets","volume":"20","author":"Bi","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.redox.2025.103827_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107922","article-title":"Genotoxic therapy and resistance mechanism in gliomas","volume":"228","author":"Lang","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.redox.2025.103827_bib21","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1158\/2159-8290.CD-20-1474","article-title":"Diffuse glioma heterogeneity and its therapeutic implications","volume":"11","author":"Nicholson","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.redox.2025.103827_bib22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","article-title":"Oxidative stress in cancer","volume":"38","author":"Hayes","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.redox.2025.103827_bib23","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s10549-010-1158-7","article-title":"Individual responses to chemotherapy-induced oxidative stress","volume":"125","author":"Il'yasova","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.redox.2025.103827_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/antiox9121300","article-title":"The effect of glutathione Peroxidase-1 knockout on anticancer drug sensitivities and reactive oxygen species in haploid HAP-1 cells","volume":"9","author":"Behnisch-Cornwell","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.redox.2025.103827_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.566","article-title":"Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma","volume":"6","author":"Singer","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.redox.2025.103827_bib26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.semcancer.2013.12.007","article-title":"The role of reactive oxygen species and metabolism on cancer cells and their microenvironment","volume":"25","author":"Costa","year":"2014","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.redox.2025.103827_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105136","article-title":"Antioxidant responses related to temozolomide resistance in glioblastoma","volume":"149","author":"Campos-Sandoval","year":"2021","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.redox.2025.103827_bib28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00204-008-0304-z","article-title":"Intracellular redox status and oxidative stress: implications for cell proliferation, apoptosis, and carcinogenesis","volume":"82","author":"Mates","year":"2008","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.redox.2025.103827_bib29","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/brain\/awab340","article-title":"An MRI radiomics approach to predict survival and tumour-infiltrating macrophages in gliomas","volume":"145","author":"Li","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.redox.2025.103827_bib30","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang da","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.redox.2025.103827_bib31","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/s41419-018-1232-3","article-title":"ALDH1A3 induces mesenchymal differentiation and serves as a predictor for survival in glioblastoma","volume":"9","author":"Li","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.redox.2025.103827_bib32","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.tips.2017.06.001","article-title":"Targeting the Thioredoxin system for cancer therapy","volume":"38","author":"Zhang","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.redox.2025.103827_bib33","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.tcb.2020.03.002","article-title":"The complex interplay between antioxidants and ROS in cancer","volume":"30","author":"Harris","year":"2020","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.redox.2025.103827_bib34","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41580-020-0250-z","article-title":"Mechanisms, regulation and functions of the unfolded protein response","volume":"21","author":"Hetz","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.redox.2025.103827_bib35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.trecan.2022.09.005","article-title":"Challenges in glioblastoma research: focus on the tumor microenvironment","volume":"9","author":"Bikfalvi","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.redox.2025.103827_bib36","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.semcancer.2020.12.015","article-title":"Epigenetics of glioblastoma multiforme: from molecular mechanisms to therapeutic approaches","volume":"83","author":"Uddin","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.redox.2025.103827_bib37","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/neuonc\/noaa033","article-title":"Superiority of temozolomide over radiotherapy for elderly patients with RTK II methylation class, MGMT promoter methylated malignant astrocytoma","volume":"22","author":"Wick","year":"2020","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.redox.2025.103827_bib38","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1093\/neuonc\/noy016","article-title":"Temozolomide-associated hypermutation in gliomas","volume":"20","author":"Choi","year":"2018","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.redox.2025.103827_bib39","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13046-022-02349-7","article-title":"Emerging therapies for glioblastoma: current state and future directions","volume":"41","author":"Rong","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.redox.2025.103827_bib40","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.canlet.2014.04.001","article-title":"The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism","volume":"356","author":"Lu","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.redox.2025.103827_bib41","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.semcdb.2017.05.023","article-title":"ROS signalling in the biology of cancer","volume":"80","author":"Moloney","year":"2018","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.redox.2025.103827_bib42","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nature11743","article-title":"Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells","volume":"493","author":"Maddocks","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.redox.2025.103827_bib43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.freeradbiomed.2018.03.019","article-title":"Oxidative stress and mitochondrial adaptive shift during pituitary tumoral growth","volume":"120","author":"Sabatino","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2025.103827_bib44","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.trecan.2021.04.003","article-title":"Enhancing the efficacy of glutamine metabolism inhibitors in cancer therapy","volume":"7","author":"Yang","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.redox.2025.103827_bib45","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.7150\/thno.56747","article-title":"The double-edged roles of ROS in cancer prevention and therapy","volume":"11","author":"Wang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.redox.2025.103827_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2018.11.019","article-title":"Curcuminoid B63 induces ROS-mediated paraptosis-like cell death by targeting TrxR1 in gastric cells","volume":"21","author":"Chen","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2025.103827_bib47","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev-pharmtox-052220-102509","article-title":"Thioredoxin reductase inhibition for cancer therapy","volume":"62","author":"Gencheva","year":"2022","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.redox.2025.103827_bib48","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1158\/0008-5472.CAN-18-1938","article-title":"Inhibition of Thioredoxin\/Thioredoxin reductase induces synthetic lethality in lung cancers with compromised glutathione homeostasis","volume":"79","author":"Yan","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.redox.2025.103827_bib49","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2174\/1389203715666140530091910","article-title":"Thioredoxin reductase and its inhibitors","volume":"15","author":"Saccoccia","year":"2014","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.redox.2025.103827_bib50","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrm3801","article-title":"Cellular mechanisms and physiological consequences of redox-dependent signalling","volume":"15","author":"Holmstrom","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.redox.2025.103827_bib51","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1089\/ars.2012.4655","article-title":"Principles in redox signaling: from chemistry to functional significance","volume":"18","author":"Bindoli","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.redox.2025.103827_bib52","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","article-title":"Reactive oxygen species (ROS) as pleiotropic physiological signalling agents","volume":"21","author":"Sies","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.redox.2025.103827_bib53","doi-asserted-by":"crossref","first-page":"R453","DOI":"10.1016\/j.cub.2014.03.034","article-title":"ROS function in redox signaling and oxidative stress","volume":"24","author":"Schieber","year":"2014","journal-title":"Curr. Biol."},{"key":"10.1016\/j.redox.2025.103827_bib54","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrc3803","article-title":"Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?","volume":"14","author":"Sabharwal","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.redox.2025.103827_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.132","article-title":"Enhancement of auranofin-induced lung cancer cell apoptosis by selenocystine, a natural inhibitor of TrxR1 in vitro and in vivo","volume":"5","author":"Fan","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.redox.2025.103827_bib56","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.redox.2017.09.014","article-title":"Butaselen prevents hepatocarcinogenesis and progression through inhibiting thioredoxin reductase activity","volume":"14","author":"Zheng","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2025.103827_bib57","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1089\/ars.2015.6378","article-title":"TrxR1 as a potent regulator of the Nrf2-Keap1 response system","volume":"23","author":"Cebula","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.redox.2025.103827_bib58","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.freeradbiomed.2019.06.005","article-title":"Curcuminoid WZ26, a TrxR1 inhibitor, effectively inhibits colon cancer cell growth and enhances cisplatin-induced cell death through the induction of ROS","volume":"141","author":"Zhang","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2025.103827_bib59","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.redox.2015.12.004","article-title":"The thioredoxin system in breast cancer cell invasion and migration","volume":"8","author":"Bhatia","year":"2016","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2025.103827_bib60","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/ncomms1382","article-title":"Crystal structure of the human thioredoxin reductase-thioredoxin complex","volume":"2","author":"Fritz-Wolf","year":"2011","journal-title":"Nat. Commun."},{"key":"10.1016\/j.redox.2025.103827_bib61","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1002\/asia.201801136","article-title":"Small molecules to target the selenoprotein Thioredoxin reductase","volume":"13","author":"Zhang","year":"2018","journal-title":"Chem. Asian J."},{"key":"10.1016\/j.redox.2025.103827_bib62","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0140-6736(17)31791-9","article-title":"Safety and efficacy of ebselen for the prevention of noise-induced hearing loss: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"390","author":"Kil","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.redox.2025.103827_bib63","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cbi.2017.07.020","article-title":"Synergism between thioredoxin reductase inhibitor ethaselen and sodium selenite in inhibiting proliferation and inducing death of human non-small cell lung cancer cells","volume":"275","author":"Zheng","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.redox.2025.103827_bib64","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00280-010-1340-y","article-title":"Phase I and pharmacologic study of BNP7787, a novel chemoprotector in patients with advanced non-small cell lung cancer","volume":"67","author":"Masuda","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.redox.2025.103827_bib65","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.trecan.2020.07.006","article-title":"Pharmacological targeting of IRE1 in cancer","volume":"6","author":"Raymundo","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.redox.2025.103827_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102833","article-title":"Loss of PERK function promotes ferroptosis by downregulating SLC7A11 (System Xc(-)) in colorectal cancer","volume":"65","author":"Saini","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2025.103827_bib67","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0092-8674(01)00611-0","article-title":"XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor","volume":"107","author":"Yoshida","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.redox.2025.103827_bib68","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2116505119","article-title":"Blocking CHOP-dependent TXNIP shuttling to mitochondria attenuates albuminuria and mitigates kidney injury in nephrotic syndrome","volume":"119","author":"Park","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2025.103827_bib69","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41467-018-08152-3","article-title":"IRE1alpha-XBP1s pathway promotes prostate cancer by activating c-MYC signaling","volume":"10","author":"Sheng","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.redox.2025.103827_bib70","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/cdd.2017.58","article-title":"When PERK inhibitors turn out to be new potent RIPK1 inhibitors: critical issues on the specificity and use of GSK2606414 and GSK2656157","volume":"24","author":"Rojas-Rivera","year":"2017","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.redox.2025.103827_bib71","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1080\/15548627.2022.2112830","article-title":"Targeting mitophagy to promote apoptosis is a potential therapeutic strategy for cancer","volume":"19","author":"Tang","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.redox.2025.103827_bib72","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1080\/15548627.2016.1277309","article-title":"PINK1 and BECN1 relocalize at mitochondria-associated membranes during mitophagy and promote ER-mitochondria tethering and autophagosome formation","volume":"13","author":"Gelmetti","year":"2017","journal-title":"Autophagy"},{"key":"10.1016\/j.redox.2025.103827_bib73","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7150\/thno.7193","article-title":"Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target?","volume":"4","author":"Kobayashi","year":"2013","journal-title":"Theranostics"}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231725003404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231725003404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T15:59:33Z","timestamp":1772899173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231725003404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":73,"alternative-id":["S2213231725003404"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2025.103827","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel Thioredoxin reductase 1 inhibitor BS1801 relieves treatment resistance and triggers endoplasmic reticulum stress by elevating reactive oxygen species in glioma","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2025.103827","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103827"}}